EC Number |
Posttranslational Modification |
Reference |
---|
2.3.2.13 | glycoprotein |
- |
-, 735846 |
2.3.2.13 | glycoprotein |
chondrosarcoma transglutaminase |
487845 |
2.3.2.13 | glycoprotein |
coagulating gland transglutaminase, glycosylated with mannosyl-residues, no terminal position, substituted with saturated acyl residues and phosphoinositol |
487848 |
2.3.2.13 | lipoprotein |
membrane-bound enzyme of keratocytes is anchored via palmitate and myristate |
487830 |
2.3.2.13 | more |
- |
487835 |
2.3.2.13 | more |
acetylation by sulfosuccinimidyl acetate or aspirin results in a loss of 90% of crosslinking activity. Residues critical for modification are K444, K468, and K663 |
706632 |
2.3.2.13 | more |
alpha-subunit of factor XIIIa is most probably not glycosylated |
487835 |
2.3.2.13 | more |
contains 4 potential N-glycosylation sites, neither typical hydrophobic leader sequence nor a transmembrane domain can be identified from gene sequence |
658504 |
2.3.2.13 | more |
no glycoprotein |
487820, 487830, 487833, 487858 |
2.3.2.13 | phosphoprotein |
phosphorylation of transglutaminase 2 (TG2) at serine-216 plays a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of phosphatase and tensin homologue deleted on chromosome 10 |
719171 |